Skip to main content

Nephrogenic systemic fibrosis: a case series suggesting gadolinium as a possible aetiological factor

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Summary

Nephrogenic systemic fibrosis (NSF) or nephrogenic fibrosing dermopathy is a rare fibrotic condition that presents in patients with a history of renal disease. The aetiology is unknown, but it has recently been proposed that gadolinium, a paramagnetic contrast agent, may be a trigger of this disease. We report three patients with NSF with a history of use of gadolinium in magnetic resonance angiography a few weeks before the onset of symptoms. In the future, gadolinium should probably be avoided as much as possible in renal insufficiency patients until its role in the development of NSF is clarified.

Keywords: gadolinium; nephrogenic fibrosing dermopathy; nephrogenic systemic fibrosis

Document Type: Research Article

DOI: https://doi.org/10.1111/j.1365-2133.2007.08067.x

Affiliations: 1: Department of Dermatology, Yale University School of Medicine, New Haven, CT 06519, U.S.A. 2: Nephrology, Hospital Clinic de Barcelona, Universitat de Barcelona, Villarroel 170, Barcelona 08036, Spain

Publication date: 2007-10-01

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more